Infectious Disease Testing Market in the US 2015-2019

Infectious Disease Testing Market in the US 2015-2019

About infectious disease testing

Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are one of the primary contributors to morbidity and mortality worldwide. According to the CDC, in the US there are more than 1.2 million people living with HIV infection and one in eight are unaware about their condition. In 2013, it was estimated that 47,352 Americans were diagnosed with HIV infection and in the same year 26,688 people were diagnosed with AIDS. Early diagnosis and treatment play an important role to prevent the long-term complications of HIV/AIDS. Molecular testing, POCT, and immunodiagnostics are used for the screening and detection the disease. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care.

Manufacturers are developing diagnostic tests that can provide results in just a few minutes. For example, Alere developed Alere BinaxNOW Influenza A&B Card, which can detect influenza A & B in 15 minutes.Technavio's analysts forecast the infectious disease testing market in the US to grow at a CAGR of 5.81% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the infectious disease testing market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of equipment and consumables from molecular diagnostics, POCT diagnostic devices, and immunodiagnostics, which are used to detect infectious diseases:

The market is segmented based on technology:

  • Molecular diagnostic test
  • POCT
  • Immunodiagnostic test
The POCT for infectious disease is further segmented based on application:
  • HIV
  • Respiratory
  • HAIs
  • Sexual health
  • Tropical diseases
  • Hepatitis
In addition, the market is segmented based on products:
  • Equipment
  • Consumables
Technavio's report, Infectious Disease Testing Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the five key vendors in the market. The vendor landscape focuses on vendors that provide access to new technologies. The report also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market.

Key vendors
  • Abbott Diagnostics
  • Alere
  • Beckman Coulter Diagnostics
  • Roche
  • Siemens Healthcare
Other prominent vendors
  • Abaxis
  • Acon Laboratories
  • Avioq
  • BD
  • Bio-Rad Laboratories
  • Cavidi
  • Cepheid
  • Chembio Diagnostic Systems
  • Clarity Diagnostics
  • EMD Millipore
  • Epitope Diagnostic
  • Gold Standard Diagnostics
  • Hologic
  • Immunetics
  • InBios International
  • Life Technologies
  • Maxim Biomedical
  • Mindray
  • OraSure Technologies
  • Ortho Clinical Diagnostics
  • Quidel Corporation
  • Thermo Fisher Scientific
  • Trinity Biotech
Market driver
  • North America free trade agreement
  • For a full, detailed list, view our report
Market challenge
  • Medical device excise tax law
  • For a full, detailed list, view our report
Market trend
  • Development of innovative diagnostics initiatives
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research Methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Market landscape
    • Market overview
      • Table Infectious disease testing market in US 2014-2019 ($ billions)
  • Infectious disease landscape in the US
    • Reimbursement in US
      • Table Average Medicare payments for infectious diseases
    • Clinical laboratory improvement amendments (CLIA) waiver from US Food and Drug Administration
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by technology
    • Table Segmentation of infectious disease testing market in US based on technology
    • Molecular diagnostic test
      • Table Molecular diagnostic testing market in US 2014-2019 ($ billions)
    • POCT for infectious diseases
      • Table POCT diagnostic testing market for infectious diseases in US 2014-2019 ($ billions)
    • Immunodiagnostic tests
      • Table Immunodiagnostic tests for infectious disease market in US 2014-2019 ($ billions)
      • Table Segmentation of infectious disease market in US by technology 2014
  • Market segmentation by application
    • Table POCT for infectious diseases market in US by application
    • Table Segmentation of POCT for infectious disease market in US 2014
  • Market segmentation by product
    • Table Infectious disease testing market in US by product
    • Equipment
    • Consumables
      • Table Segmentation of infectious disease testing market in US by product 2014
  • Market drivers
    • NAFTA
    • Demand for rapid and automated diagnostics
    • Shift toward patient-centered model
    • Focus on disease management
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Medical device excise tax law
    • Increase in globalization
    • New microbial diseases
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Development of innovative diagnostics initiatives
    • Key role of US Army Medical Research Institute in Diagnostics and Development (USAMRIID)
    • Low-cost microfluidic devices for POCT
    • Focus on early diagnosis of infectious diseases
  • Vendor landscape
    • Competitive scenario
    • Abbott Diagnostics
      • Table Key Takeaways: Abbott Diagnostics
    • Alere
      • Table Key takeaways: Alere
    • Roche Diagnostics
      • Table Key takeaways: Roche Diagnostics
    • Siemens Healthcare
      • Table Key takeaways: Siemens Healthcare
    • Beckman Coulter Diagnostics
      • Table Key takeaways: Beckman Coulter Diagnostics
    • Other prominent vendors
  • Key vendor analysis
    • Abbott Diagnostics
      • Table Abbott Diagnostics: Key business offerings
    • Alere
      • Table Alere: Business segmentation by revenue 2014
      • Table Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
      • Table Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
    • Beckman Coulter
      • Table Beckman Coulter: Business segmentation
    • Roche Diagnostics
      • Table Roche Diagnostics: Business segmentation by revenue 2014
      • Table Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table Roche Diagnostics: Segmentation of revenue by regions 2014
    • Siemens Healthcare
      • Table Siemens Healthcare: Business segmentation
      • Table Siemens Healthcare: Segmentation of revenue by geography 2014
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook